Development of a tumor targeting method using artificial intelligence/augmented reality for precise tumor resection in breast cancer patients and verification of safety and accuracy through clinical application

Development of a tumor-targeting method using artificial intelligence/augmented reality for precise tumor resection in breast cancer patients and verification of safety and accuracy through clinical application

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006634

Enrollment

Registered

2021-10-05

Start date

2021-09-22

Completion date

Unknown

Last updated

2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Based on CT/MRI of a breast cancer patient, 3D segmented tumor area is marked on the patient's skin using augmented reality

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: * Female patients from 20 to 79 years of ages * Female patients who are scheduled to have breast-conserving surgery * Subjects who fully understands and agrees in writing to the informed consent form

Exclusion criteria

Exclusion criteria: a. Patients scheduled for total mastectomy b. Patients who have contraindications of MRI - Those with an inserted electrical device, clip for the prevention of aneurysm, artificial of metallic material around the eyeball - Patients who have Claustrophobia - Patients with difficulty using gadolinium-based angiography - severe allergic or impaired of kidney function ( creatinine > 2.0) - Pregnant c. Difficult partial resection due to large calcification lesions d. Patients deemed unsuitable to participate in this clinical trial at the Investigator's discretion

Design outcomes

Primary

Measure	Time frame
Consistency between tumor-marked areas by conventional method and tumor-marked area by AR method	—

Secondary

Measure	Time frame
Tumor invasion status of resection margin;Distance from resection margin to tumor	—

Countries

Korea, Republic of

Contacts

Public ContactMunju Jeong

Asan Medical Center

mjoo0608@gmail.com+82-2-3010-6194

Outcome results